Edition:
India

Cerus Corp (CERS.OQ)

CERS.OQ on NASDAQ Stock Exchange Global Market

6.65USD
2:29am IST
Change (% chg)

$0.07 (+1.06%)
Prev Close
$6.58
Open
$6.70
Day's High
$6.80
Day's Low
$6.46
Volume
941,119
Avg. Vol
556,711
52-wk High
$7.90
52-wk Low
$2.71

Latest Key Developments (Source: Significant Developments)

Cerus Corporation Announces FDA Approval For INTERCEPT Blood System for Cryoprecipitation
Monday, 30 Nov 2020 

Nov 30 (Reuters) - Cerus Corp ::CERUS CORPORATION ANNOUNCES FDA APPROVAL FOR INTERCEPT BLOOD SYSTEM FOR CRYOPRECIPITATION.  Full Article

Cerus Corporation Announces Record Third Quarter 2020 Results
Friday, 30 Oct 2020 

Oct 29 (Reuters) - Cerus Corp ::ORATION ANNOUNCES RECORD THIRD QUARTER 2020 RESULTS.Q3 LOSS PER SHARE $0.08.Q3 EARNINGS PER SHARE ESTIMATE $-0.10 -- REFINITIV IBES DATA.Q3 REVENUE $29.2 MILLION VERSUS REFINITIV IBES ESTIMATE OF $28.6 MILLION.NARROWING FULL YEAR PRODUCT REVENUE GUIDANCE TO A RANGE OF $89 MILLION TO $91 MILLION.  Full Article

Cerus Says Entered Into Credit Agreement
Tuesday, 2 Apr 2019 

April 1 (Reuters) - Cerus Corp ::CERUS CORP SAYS ON MARCH 29, CO ENTERED INTO A CREDIT, SECURITY AND GUARANTY AGREEMENT - SEC FILING.CERUS CORP - TERM LOAN CREDIT AGREEMENT PROVIDES A SECURED TERM LOAN FACILITY IN AN AGGREGATE PRINCIPAL AMOUNT OF UP TO $70.0 MILLION.  Full Article

Cerus Expects Full Year 2018 Product Revenue To Be $60.9 Million
Monday, 7 Jan 2019 

Jan 7 (Reuters) - Cerus Corp ::CERUS ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2018 PRODUCT REVENUE.2019 PRODUCT REVENUE GUIDANCE OF $70 MILLION TO $73 MILLION.UNAUDITED PRELIMINARY PRODUCT REVENUE FOR Q4 OF 2018 TOTALED $16.5 MILLION.EXPECTS FULL YEAR 2018 PRODUCT REVENUE TO BE $60.9 MILLION.Q4 REVENUE VIEW $19.9 MILLION -- REFINITIV IBES DATA.FY2018 REVENUE VIEW $74.2 MILLION -- REFINITIV IBES DATA.  Full Article

BRIEF-Cerus Corp Reports Successful Inactivation Of Sars-Cov-2 With The Intercept Blood System For Plasma

* CERUS CORPORATION REPORTS SUCCESSFUL INACTIVATION OF SARS-COV-2 WITH THE INTERCEPT BLOOD SYSTEM FOR PLASMA